Healthcare entity
Every one of those 1 sits in a single category, market-trends. AMVUTTRA is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Healthcare story that mention Journal of the American College of Cardiology, all published on August 31, 2026.
Last mentioned: Aug 31, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. AMVUTTRA is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Healthcare story that mention Journal of the American College of Cardiology, all published on August 31, 2026. Each carries 3 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Journal of the American College of Cardiology. Shared-story counts are live from our verified record — not editorial picks.
New ESC 2026 data suggest RNAi therapy vutrisiran provides consistent cardiovascular benefit in ATTR cardiomyopathy patients regardless of baseline tafamidis use, with implications for cardiology treatment pathways and broader hypertension management.
Journal of the American College of Cardiology is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
